Praxis Precision Medicines

Last updated: May 01, 2024

Marcio Souza, CEO
Marcio Souza, CEO
Country: USA | Funding: $573.1M (+)

Website: https://www.praxismedicines.com/

Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders